Category: News

Updated results from a survey first published in the AACR Cancer Disparities Report 2026 reveal the impact of federal policy changes on cancer disparities researchers. Additional highlights from the report were also shared during a session at 19th AACR Conference on The Science of Cancer Health Disparities where a panel of speakers addressed the progress made in addressing cancer disparities and the need to continue to support research in this field.

The post How Federal Policy Changes Are Affecting Cancer Disparities Research: Findings From an AACR Survey appeared first on American Association for Cancer Research (AACR).

At the AACR Conference on The Science of Cancer Health Disparities, Justin Xavier Moore, PhD, MPH, of the University of Kentucky, shared a study on how neighborhood disadvantage impacts mortality rates for early-onset colorectal cancer. And Jordan Baeker Bispo, PhD, MPH, of the American Cancer Society, presented survey results about whether doctors discuss the different colorectal cancer screening options with younger patients who are newly eligible for screening.

The post Why Do Some Communities Experience Disparities in Early-onset Colorectal Cancer Screening and Survival? appeared first on American Association for Cancer Research (AACR).

The 18th Frontiers in Cancer Science conference, to be held November 11-13 in Singapore, will explore what cancer’s past can tell us about its future. The conference cochairs Gopal Iyer, MBBS (Hons), PhD, and Choon Kiat Ong, PhD, preview what else attendees can expect from this year’s scientific and education sessions.

The post Frontiers in Cancer Science 2026: What Can Cancer’s Past Tell Us About Its Future? appeared first on American Association for Cancer Research (AACR).

Like millions of people, Pope Leo XIV was diagnosed with lung cancer. This disease, though still serious, has also been transformed from one of daunting odds to a surmountable affliction thanks to decades of sustained effort in cancer research. This summary of that progress assesses how far research has come in combatting lung cancer and how much more work there is to do.

The post Survival From Lung Cancer, Including the Type That Pope Leo XIV Has, Continues to Improve Thanks to Sustained Cancer Research Progress appeared first on American Association for Cancer Research (AACR).

At the recent AACR Conference on Pancreatic Cancer, Kevan M. Shokat, PhD, FAACR, received the 2026 Stephenson Global Prize for his pioneering discoveries that opened the door to the development of RAS-targeted therapies. Read the post to learn more on the scientific journey that led to new drugs for cancer treatment, including the first major systemic therapy advance in metastatic pancreatic cancer in more than a decade.

The post A New Way In: How Outside-the-box Science Sparked a Revolution in Targeting KRAS appeared first on American Association for Cancer Research (AACR).

The Friends of the AACR Foundation will honor Domenick Bucci, MD, as the Humanitarian Honoree and the HEADstrong Foundation as the Community Impact Award recipient at this year’s Party with a Purpose. Learn more about their humanitarian and charity efforts prior to the gala on October 25.

The post Party With a Purpose Honors Domenick Bucci, MD, and the HEADstrong Foundation appeared first on American Association for Cancer Research (AACR).

The fall issue of Cancer Today explores treatment advances for people with multiple myeloma whose cancer has returned or stopped responding to treatment, including CAR T-cell therapies and bispecific antibodies. The issue also covers the expanding role of antibody-drug conjugates, a drug that can boost the effectiveness of chemotherapy for platinum-resistant epithelial ovarian cancer, activity-based support groups for cancer survivors, and more.

The post Cancer Today’s Fall 2026 Issue: Activity-based Groups for Survivors, Expanding Treatment Options in Multiple Myeloma, and More appeared first on American Association for Cancer Research (AACR).

Salivary gland cancer is rare, and there are no standard treatments for advanced-stage disease. Recent research supports the use of HER2-targeted therapy for patients with metastatic or recurrent salivary gland cancer with HER2 overexpression.

The post HER2-targeted Therapy for Salivary Gland Cancer appeared first on American Association for Cancer Research (AACR).

During the third quarter of 2026, the U.S. Food and Drug Administration approved cancer treatments that expanded the options for patients with skin, genitourinary, breast, lung, gastroesophageal, pancreatic, and bile duct cancers, as well as several hematologic malignancies and solid tumors with certain features. Learn about each new approval and how it fits into the therapeutic landscape.

The post FDA Approvals in Oncology: July-September 2026 appeared first on American Association for Cancer Research (AACR).

The second installment of Cancer Research Catalyst’s new monthly series, “Unboxing Cancer News,” highlights exciting cancer research discoveries reported during September, including the effects of early-life sugar restriction on cancer risk, the potential of a hallucinogenic compound to prevent chemotherapy-related pain, surgical de-escalation for patients with head and neck cancers, and a genetic risk factor for lung cancer in never-smokers.

The post Unboxing Cancer News, September 2026: Sugar and Cancer Risk, Psilocybin’s Chemotherapy Relief, and More appeared first on American Association for Cancer Research (AACR).